August 15, 2026 — RNews

#combination therapy — Saturday, August 15, 2026 (1 items)

hot top new

← prev day next day →

0

Sintilimab plus Bevacizumab biosimilar IBI305 and chemotherapy as a first-line treatment in advanced gastric or gastroesophageal junction adenocarcinoma (SBAGA): a single-arm, phase Ib/II study. (nature.com)

Cheng M … Liu M Nature Communications 2026-08-15

#immunotherapy #gastric cancer #clinical trial #combination therapy #angiogenesis